Johnson & Johnson vaccine back in use

Missouri is resuming the use of the Johnson & Johnson COVID-19 vaccine after federal scientific advisers decided its benefits outweigh a rare risk of blood clots.

The state of Missouri made the announcement Friday in a tweet in response to U.S. health officials lifting an 11-day pause on the single-dose vaccine.   

The state said that providers with the J&J vaccine in-stock can immediately begin administering it and that shipments from the federal government will resume next week. 

Just over 105,000 doses of J&J had been administered in Missouri before the pause.